Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Assets (2023 - 2025)

Cannabis Bioscience International Holdings filings provide 3 years of Non-Current Assets readings, the most recent being $2795.0 for Q2 2025.

  • On a quarterly basis, Non-Current Assets fell 92.16% to $2795.0 in Q2 2025 year-over-year; TTM through Feb 2026 was $2795.0, a 97.02% decrease, with the full-year FY2025 number at $2795.0, down 92.16% from a year prior.
  • Non-Current Assets reached $2795.0 in Q2 2025 per CBIH's latest filing, down from $11100.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $82103.0 in Q4 2023, with the low at $2795.0 in Q2 2025.
  • A 3-year average of $34751.6 and a median of $25728.5 in 2023 define the central range for Non-Current Assets.
  • Year-over-year, Non-Current Assets skyrocketed 49.12% in 2024 and then tumbled 92.16% in 2025.
  • Year by year, Non-Current Assets stood at $82103.0 in 2023, then tumbled by 76.44% to $19347.0 in 2024, then crashed by 85.55% to $2795.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Non-Current Assets are $2795.0 (Q2 2025), $11100.0 (Q1 2025), and $19347.0 (Q4 2024).